Zachary Bogue
CIK 1836157 · View on SEC EDGAR ↗
Insider
First SEC filing: April 15, 2021 · Latest: April 15, 2021
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 24 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 3, 2023 | RXRX | A | 1,440 | — | — | 9,378 Direct | +18.14% | Acquired | (price as of 2026-08-21) |
| April 3, 2023 | RXRX | A | 1,542 | — | — | 7,938 Direct | +24.11% | Acquired | (price as of 2026-08-21) |
| Jan. 3, 2023 | RXRX | A | 1,407 | — | — | 6,396 Direct | +28.20% | Acquired | (price as of 2026-08-21) |
| Oct. 3, 2022 | RXRX | A | 977 | — | — | 4,989 Direct | +24.35% | Acquired | (price as of 2026-08-21) |
| July 1, 2022 | RXRX | A | 1,260 | — | — | 4,012 Direct | +45.78% | Acquired | (price as of 2026-08-21) |
| April 1, 2022 | RXRX | A | 1,382 | — | — | 2,752 Direct | +100.88% | Acquired | (price as of 2026-08-21) |
| Jan. 3, 2022 | RXRX | A | 589 | — | — | 1,370 Direct | +75.42% | Acquired | (price as of 2026-08-21) |
| Oct. 1, 2021 | RXRX | A | 295 | — | — | 781 Direct | +60.70% | Acquired | (price as of 2026-08-21) |
| July 1, 2021 | RXRX | A | 295 | — | — | 295 Direct | — | Acquired | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 3,726,963 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 730,353 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 1,095,529 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 3,220,788 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 1,073,595 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 3,771,996 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | J | 3,726,963 | — | — | 3,726,963 Indirect | — | Acquired | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | J | 3,726,963 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 3,726,963 | — | — | 3,726,963 Indirect | — | Acquired | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | J | 3,951,141 | — | — | 3,951,141 Indirect | — | Acquired | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | J | 3,951,141 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 3,951,141 | — | — | 3,951,141 Indirect | — | Acquired | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | J | 5,941,120 | — | — | 5,941,120 Indirect | — | Acquired | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | J | 5,941,120 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-21) |
| April 20, 2021 | RXRX | C | 5,941,120 | — | — | 5,941,120 Indirect | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 20, 2021 | RXRX | Series D Preferred Stock | Common Stock [F1] (3,726,963) | — | — | 3,726,963 | Disposed |
| April 20, 2021 | RXRX | Series C Preferred Stock | Common Stock [F1] (730,353) | — | — | 730,353 | Disposed |
| April 20, 2021 | RXRX | Series C Preferred Stock | Common Stock [F1] (1,095,529) | — | — | 1,095,529 | Disposed |
| April 20, 2021 | RXRX | Series B Preferred Stock | Common Stock [F1] (3,220,788) | — | — | 3,220,788 | Disposed |
| April 20, 2021 | RXRX | Series B Preferred Stock | Common Stock [F1] (1,073,595) | — | — | 1,073,595 | Disposed |
| April 20, 2021 | RXRX | Series A Preferred Stock | Common Stock [F1] (3,771,996) | — | — | 3,771,996 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 15, 2021 | RXRX | Series A Preferred Stock→ Common Stock [F1] (3,771,996) | 3,771,996 | Indirect |
| April 15, 2021 | RXRX | Series B Preferred Stock→ Common Stock [F1] (1,073,595) | 1,073,595 | Indirect |
| April 15, 2021 | RXRX | Series B Preferred Stock→ Common Stock [F1] (3,220,788) | 3,220,788 | Indirect |
| April 15, 2021 | RXRX | Series C Preferred Stock→ Common Stock [F1] (1,095,529) | 1,095,529 | Indirect |
| April 15, 2021 | RXRX | Series C Preferred Stock→ Common Stock [F1] (730,353) | 730,353 | Indirect |
| April 15, 2021 | RXRX | Series D Preferred Stock→ Common Stock [F1] (3,726,963) | 3,726,963 | Indirect |